MedPath

Tramadol

Generic Name
Tramadol
Brand Names
Conzip, Durela, Qdolo, Ralivia, Ryzolt, Seglentis, Tridural, Ultracet, Ultram, Zytram
Drug Type
Small Molecule
Chemical Formula
C16H25NO2
CAS Number
27203-92-5
Unique Ingredient Identifier
39J1LGJ30J
Background

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of action, tramadol is generally considered a lower-risk opioid option for the treatment of moderate to severe pain. It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of morphine.

Tramadol differs from other traditional opioid medications in that it doesn't just act as a μ-opioid agonist, but also affects monoamines by modulating the effects of neurotransmitters involved in the modulation of pain such as serotonin and norepinpehrine which activate descending pain inhibitory pathways. Tramadol's effects on serotonin and norepinephrine mimic the effects of other SNRI antidepressants such as duloxetine and venlafaxine.

Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms and are also themselves metabolized into active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol's ability to modulate the perception of and response to pain.

Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators. Due to the broad spectrum of targets involved in pain and inflammation, it's not surprising that the evidence has shown that tramadol is effective for a number of pain types including neuropathic pain, post-operative pain, lower back pain, as well as pain associated with labour, osteoarthritis, fibromyalgia, and cancer. Due to its SNRI activity, tramadol also has anxiolytic, antidepressant, and anti-shivering effects which are all frequently found as comorbidities with pain.

Similar to other opioid medications, tramadol poses a risk for development of tolerance, dependence and abuse. If used in higher doses, or with other opioids, there is a dose-related risk of overdose, respiratory depression, and death. However, unlike other opioid medications, tramadol use also carries a risk of seizure and serotonin syndrome, particularly if used with other serotonergic medications.

Indication

Tramadol is approved for the management of moderate to severe pain in adults.

Tramadol is also used off-label in the treatment of premature ejaculation.

Associated Conditions
Acute Pain, Premature Ejaculation, Severe Pain, Acute, moderate, severe Pain, Moderate Pain

The Effect of Intraoperative Tramadol on Postoperative Opioid

Not Applicable
Completed
Conditions
Postoperative Pain
Interventions
First Posted Date
2023-01-25
Last Posted Date
2023-01-25
Lead Sponsor
Mansoura University
Target Recruit Count
400
Registration Number
NCT05696886
Locations
🇪🇬

Ayman El Nakeeb, Mansoura, Outside U.S And Canada, Egypt

Compair Efficacy of iv Dexmedetomidine & Tramadol for Post Spinal Shivering in Obs Patients Undergoing Cesarean Section

Phase 2
Not yet recruiting
Conditions
Post Spinal Shivering
Interventions
First Posted Date
2022-11-15
Last Posted Date
2022-11-15
Lead Sponsor
Sana Bahadur
Target Recruit Count
100
Registration Number
NCT05616364

Use of Tramadol Intraligamentary Injections

Not Applicable
Completed
Conditions
Pulpitis
Interventions
First Posted Date
2022-09-13
Last Posted Date
2022-12-19
Lead Sponsor
Jamia Millia Islamia
Target Recruit Count
105
Registration Number
NCT05538052
Locations
🇮🇳

Faculty of Dentistry, Jamia MIliia Islamia, New Delhi, India

Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination

Phase 1
Completed
Conditions
Healthy
First Posted Date
2022-09-08
Last Posted Date
2022-09-09
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
42
Registration Number
NCT05533073
Locations
🇲🇽

Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico

Comparison of Preoperative Analgesics on the Efficacy of Inferior Alveolar Nerve Block.

Phase 4
Completed
Conditions
Symptomatic Irreversible Pulpitis
Interventions
First Posted Date
2022-08-05
Last Posted Date
2022-08-05
Lead Sponsor
Farjad Zafar
Target Recruit Count
120
Registration Number
NCT05488925
Locations
🇵🇰

Department of Operative Dentistry, Baqai Dental College, Baqai Medical University., Karachi, Sindh, Pakistan

Opioid-Free Pain Protocol After Shoulder Arthroplasty

First Posted Date
2022-08-05
Last Posted Date
2025-02-17
Lead Sponsor
Henry Ford Health System
Target Recruit Count
80
Registration Number
NCT05488847
Locations
🇺🇸

Henry Ford Health, Detroit, Michigan, United States

A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.

Phase 2
Conditions
Pain
Interventions
Drug: HR18042 tablets
Drug: Placebos
First Posted Date
2022-07-22
Last Posted Date
2022-08-31
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Target Recruit Count
180
Registration Number
NCT05470075
Locations
🇨🇳

West China Hospital of Stomatology Sichuan University, Chengdu, Sichuan, China

Efficacy of Intravenous Ibuprofen and Paracetamol on Postoperative Pain and Tramadol Consumption in Shoulder Surgery

Not Applicable
Completed
Conditions
Postoperative Pain Management
Interventions
First Posted Date
2022-06-02
Last Posted Date
2023-08-18
Lead Sponsor
Bezmialem Vakif University
Target Recruit Count
2
Registration Number
NCT05401916
Locations
🇹🇷

Muhittin Calim, Istanbul, Fatih, Turkey

Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg
First Posted Date
2022-05-25
Last Posted Date
2024-11-13
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
30
Registration Number
NCT05389150
Locations
🇲🇽

Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment

Phase 3
Completed
Conditions
Postoperative Analgesia
Interventions
First Posted Date
2022-05-25
Last Posted Date
2023-04-04
Lead Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Target Recruit Count
387
Registration Number
NCT05390905
Locations
🇨🇳

Union Hospital, Tongji Medical College, Huazhong U, Wuhan, China

© Copyright 2025. All Rights Reserved by MedPath